Search results for " market"
Article
Genetic Vaccine Platforms Demonstrate Their Potential
“Traditional vaccines have been on the market much longer than genetic vaccines and, in most cases, can currently be made at a significantly lower cost,” Bleck. “Over time,” he adds, “these technologi…
Article
Reimagining Affordable Biosimilars
More than 300 active biopharmaceutical product licenses in the market today bear witness to increasing interest in targeted treatments. With an anticipated valuation of over $200 billion by 2022, this…
Article
Next Generation Process Chromatography
Seven years later, Cytiva would bring Fibro to the market following the acquisition of Puridify in 2017.
Fibro is a new chromatography platform that enables the purification of therapeutic antibod…
Article
Successfully Moving Regulated Data to the Cloud
But the real benefit is how an expedited submission process can reduce the time it takes to get a new drug to market, which benefits the consumer.
Managing ever-increasing quantities of data
Bec…
Article
Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
SPR provides a meaningful insight into the characterization of biotherapeutics and comparability of biosimilars present in the market.
Conclusion
This review has demonstrated that SPR is a rap…
Article
Advances in Engineering of Protein-Based APIs
Amgen’s XenoMouse technology has been used to produce the marketed mAb therapeutics denosumab, erenumab, and evolocumab.
Recently, more fully human platform technologies have been developed, suc…
Article
CDMOs Driving Emerging Bio/Pharma Success
Analysts who track the industry expect 2018 to be the sixth straight year of substantial new investment in emerging biopharma companies from venture capital, public markets, and partnering. Funding fo…
Article
Biopharma Says It Has an Evolution in New Technologies and Processes
Q: Can biologic-based drug developers learn any lessons from the continuous manufacturing experiences of the small-molecule market segment?
A: A BioPharm International panel discussion on the outl…
Article
Making the Move to Continuous Chromatography
Different vendors offer different formats; in some cases up to eight columns can be used, according to Peter Levison, senior marketing director for downstream processing at Pall Biotech. “Multicolumn …
Article
Reliability Rooms and the Move to Proactive Supply Chain Management
For example, there is a statistical correlation between certain metrics that are associated with stock outs in specific markets, which are fed by certain sites. Knowing these correlations allows targe…